estrone has been researched along with Atrophy in 22 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Excerpt | Relevance | Reference |
---|---|---|
"To study the relationship between ovarian production of estrone (E ), estradiol (E2), testosterone (T), and androstenedione (A) and the ovarian degree of stromal hyperplasia in postmenopausal women." | 7.70 | Relationship between ovarian production of estrone, estradiol, testosterone, and androstenedione and the ovarian degree of stromal hyperplasia in postmenopausal women. ( de Jong, FH; Evers, JL; Heineman, MJ; Koudstaal, J; Sluijmer, AV; Theunissen, PH, 1998) |
"Vaginal promestriene was tested in gynecological cancer patients who suffered from severe vaginal dryness and dyspareunia." | 5.16 | Effect of one-month treatment with vaginal promestriene on serum estrone sulfate levels in cancer patients: a pilot study. ( Corona, G; Del Pup, L; Postruznik, D, 2012) |
" Daily oral MPG (1000 mg/kg body weight) for 2 weeks significantly recovered uterine and adrenal gland atrophy and restored serum estradiol, estrone and progesterone levels that were decreased in rats by bilateral ovariectomy." | 3.76 | Estrogenic effects of the herbal formula, menoprogen, in ovariectomized rats. ( Chung, MH; Hattori, M; Lu, Y; Ma, H; Nishihara, T, 2010) |
"To study the relationship between ovarian production of estrone (E ), estradiol (E2), testosterone (T), and androstenedione (A) and the ovarian degree of stromal hyperplasia in postmenopausal women." | 3.70 | Relationship between ovarian production of estrone, estradiol, testosterone, and androstenedione and the ovarian degree of stromal hyperplasia in postmenopausal women. ( de Jong, FH; Evers, JL; Heineman, MJ; Koudstaal, J; Sluijmer, AV; Theunissen, PH, 1998) |
"Plasma levels of oestrone and oestradiol-17beta were determined at 20 or 30 minute intervals for up to 24 hours in 26 postmenopausal or ovariectomised women of similar age, weight, and number of years since menopause or operation." | 3.66 | Relation between plasma oestrone and oestradiol and climacteric symptoms. ( Hutton, JD; Jacobs, HS; James, VH; Murray, MA, 1978) |
"The finding of this study shows that lower dosage of piperazinyl estrone has effect on preventing the bone losses in OVX rats, while the bone formation and the uterus are not affected, thus supporting the hypothesis that piperazinyl estrone has the potential to prevent postmenopausal bone loss in women with less side effects." | 1.32 | [Piperazinyl estrone prevents bone loss in ovariectomized rats]. ( Chen, HQ; Hu, B; Huang, LF; Li, QN; Weng, LL; Zheng, H, 2003) |
"Tamoxifen treatment, on the other hand, produced an increase in both the number and crowding of the endometrial glands and a mild atrophy of the myometrial layer." | 1.30 | Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice. ( Belanger, A; Gauthier, S; Labrie, C; Labrie, F; Luo, S; Martel, C; Mérand, Y; Sourla, A, 1997) |
"Estrone levels were not measurable with a sensitive RIA technique." | 1.28 | Endogenous estrogen levels in postmenopausal women with severe urogenital atrophy. ( Heimer, G; Nilsson, K, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (45.45) | 18.7374 |
1990's | 6 (27.27) | 18.2507 |
2000's | 2 (9.09) | 29.6817 |
2010's | 4 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ke, Y | 1 |
Bélanger, A | 2 |
Simard, JN | 1 |
Gonthier, R | 1 |
Martel, C | 2 |
Vaillancourt, M | 1 |
Labrie, F | 2 |
Ma, H | 1 |
Chung, MH | 1 |
Lu, Y | 1 |
Nishihara, T | 1 |
Hattori, M | 1 |
Dorr, MB | 1 |
Nelson, AL | 1 |
Mayer, PR | 1 |
Ranganath, RP | 1 |
Norris, PM | 1 |
Helzner, EC | 1 |
Preston, RA | 1 |
Del Pup, L | 1 |
Postruznik, D | 1 |
Corona, G | 1 |
Li, QN | 1 |
Weng, LL | 1 |
Huang, LF | 1 |
Hu, B | 1 |
Chen, HQ | 1 |
Zheng, H | 1 |
Vardy, MD | 1 |
Lindsay, R | 1 |
Scotti, RJ | 1 |
Mikhail, M | 1 |
Richart, RM | 1 |
Nieves, J | 1 |
Zion, M | 1 |
Cosman, F | 1 |
Luisi, M | 1 |
Franchi, F | 1 |
Kicovic, PM | 1 |
Notelovitz, M | 1 |
Aiman, J | 1 |
Brenner, PF | 1 |
MacDonald, PC | 1 |
Handa, VL | 1 |
Bachus, KE | 1 |
Johnston, WW | 1 |
Robboy, SJ | 1 |
Hammond, CB | 1 |
Naessen, T | 1 |
Berglund, L | 1 |
Ulmsten, U | 1 |
Luo, S | 1 |
Sourla, A | 1 |
Gauthier, S | 1 |
Mérand, Y | 1 |
Labrie, C | 1 |
Sluijmer, AV | 1 |
Heineman, MJ | 1 |
Koudstaal, J | 1 |
Theunissen, PH | 1 |
de Jong, FH | 1 |
Evers, JL | 1 |
Hutton, JD | 1 |
Jacobs, HS | 1 |
Murray, MA | 1 |
James, VH | 1 |
Studd, J | 1 |
Nilsson, K | 2 |
Heimer, G | 2 |
Varma, TR | 1 |
Trévoux, R | 1 |
De Brux, J | 1 |
Castanier, M | 1 |
Nahoul, K | 1 |
Soule, JP | 1 |
Scholler, R | 1 |
Weniger, JP | 1 |
Aylward, M | 1 |
Holly, F | 1 |
Parker, RJ | 1 |
Procopé, BJ | 1 |
Adlercreutz, H | 1 |
6 trials available for estrone and Atrophy
Article | Year |
---|---|
Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis.
Topics: Administration, Intravaginal; Administration, Oral; Aged; Atrophy; Cross-Over Studies; Drug Administ | 2010 |
Effect of one-month treatment with vaginal promestriene on serum estrone sulfate levels in cancer patients: a pilot study.
Topics: Adult; Aged; Atrophy; Dyspareunia; Estradiol; Estrogens; Estrone; Female; Genital Neoplasms, Female; | 2012 |
Short-term urogenital effects of raloxifene, tamoxifen, and estrogen.
Topics: Aged; Atrophy; Double-Blind Method; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Fema | 2003 |
Bone loss in elderly women prevented by ultralow doses of parenteral 17beta-estradiol.
Topics: Administration, Intravaginal; Aged; Aging; Alkaline Phosphatase; Analysis of Variance; Atrophy; Bone | 1997 |
Low-dose oestradiol in the treatment of urogenital oestrogen deficiency--a pharmacokinetic and pharmacodynamic study.
Topics: Administration, Intravaginal; Aged; Atrophy; Double-Blind Method; Epithelium; Estradiol; Estrone; Fe | 1992 |
An evaluation of clinical response to piperazine oestrone sulphate ('Harmogen') in menopause patients.
Topics: Adult; Amenorrhea; Atrophy; Clinical Trials as Topic; Estradiol Congeners; Estrogens; Estrogens, Con | 1974 |
16 other studies available for estrone and Atrophy
Article | Year |
---|---|
Concentration range of serum sex steroids in normal postmenopausal women and those with diagnosis of vulvovaginal atrophy.
Topics: Aged; Androsterone; Atrophy; Case-Control Studies; Clinical Trials as Topic; Dehydroepiandrosterone | 2018 |
Estrogenic effects of the herbal formula, menoprogen, in ovariectomized rats.
Topics: Adrenal Glands; Animals; Atrophy; Drugs, Chinese Herbal; Estradiol; Estrone; Female; Gonadal Steroid | 2010 |
[Piperazinyl estrone prevents bone loss in ovariectomized rats].
Topics: Animals; Atrophy; Bone Density; Estradiol Congeners; Estrone; Female; Organ Size; Osteogenesis; Oste | 2003 |
A group-comparative study of effects of Ovestin cream versus Premarin cream in post-menopausal women with vaginal atrophy.
Topics: Aged; Atrophy; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone | 1980 |
When and how to use estrogen therapy in women over 60.
Topics: Aged; Atrophy; Cystitis; Dose-Response Relationship, Drug; Estradiol; Estradiol Congeners; Estrogens | 1980 |
Androgen and estrogen production in elderly men with gynecomastia and testicular atrophy after mumps orchitis.
Topics: Aged; Androstenedione; Atrophy; Estradiol; Estrone; Follicle Stimulating Hormone; Gynecomastia; Huma | 1980 |
Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium.
Topics: Administration, Intravaginal; Aged; Atrophy; Biopsy; Blood Flow Velocity; Cell Division; Endometrium | 1994 |
Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstenedione; Animals; Atrophy; Benzopyrans; Drug Administratio | 1997 |
Relationship between ovarian production of estrone, estradiol, testosterone, and androstenedione and the ovarian degree of stromal hyperplasia in postmenopausal women.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Androstenedione; Atrophy; Estradiol; Estrone; Female; | 1998 |
Relation between plasma oestrone and oestradiol and climacteric symptoms.
Topics: Adult; Atrophy; Castration; Climacteric; Dyspareunia; Estradiol; Estrone; Female; Humans; Menopause; | 1978 |
Management of the menopause.
Topics: Atrophy; Climacteric; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Ethinyl Estradiol; | 1976 |
Endogenous estrogen levels in postmenopausal women with severe urogenital atrophy.
Topics: Atrophy; Circadian Rhythm; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Urethra; Vagi | 1992 |
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combi | 1985 |
Endometrium and plasma hormone profile in the peri-menopause and post-menopause.
Topics: Atrophy; Endometrium; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing | 1986 |
[Secretion of estrone, estradiol, estriol, and epiestriol by the atrophied right gonad of the female chick embryo cultivated in vitro].
Topics: Acetates; Animals; Atrophy; Carbon Isotopes; Chick Embryo; Chromatography, Thin Layer; Culture Techn | 1969 |
Studies on the influence of age on oestrogens in post-menopausal women with atrophic endometrium and normal liver function.
Topics: Age Factors; Aged; Aging; Atrophy; Castration; Endometrium; Estradiol; Estriol; Estrogens; Estrone; | 1969 |